EudraCT2013‐00117820.

Trial name or title	Cardiovascular risk prediction and biomarkers in renal transplant recipients treated with belatacept compared to calcineurin inhibitors
Methods	Open label RCT
Participants	Adult recipients of living or deceased‐donor kidney transplants
Interventions	Belatacept versus CNI
Outcomes	Primary: cardiovascular risk calculated by risk calculator in transplant recipients Secondary: blood pressure, lipids, glucose, graft function
Starting date	October 2013
Contact information	Elin Karlberg, Uppsala University Hospital, Sweden
Notes